P436 Malignancies in children receiving infliximab and other inflammatory bowel disease therapies: an inflammatory bowel disease multicenter, prospective, long-term registry of pediatric patients (DEVELOP) registry dataRichard B. Colletti, Gigi Veereman, William A. Faubion et al.|Journal of Crohn s and Colitis|2013Cited by 3
Risk of malignancy in paediatric inflammatory bowel disease: results from the DEVELOP registryM Dubinsky, Meena Thayu, Jeffrey Hyams et al.|Journal of Crohns & Colitis|2016Cited by 0